Literature DB >> 11576070

Molecular mechanisms of corticosteroids in allergic diseases.

P J Barnes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11576070     DOI： 10.1034/j.1398-9995.2001.00001.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  17 in total

Review 1.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

Review 3.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

Review 4.  Estrogen, NFkappaB, and the heat shock response.

Authors:  James P Stice; Anne A Knowlton
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 5.  Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy.

Authors:  P S Satheeshkumar; Minu P Mohan
Journal:  Dig Dis Sci       Date:  2014-07-01       Impact factor: 3.199

6.  [Effect of methyl eugenol on nasal mucosal aquaporin 5 in rats with allergic rhinitis].

Authors:  N Wu; X L Zhang; Y Hou; L X Lin; X B Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

7.  Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium.

Authors:  Evelyn Hartmann; Hendrik Graefe; Anne Hopert; Ralph Pries; Simon Rothenfusser; Hendrik Poeck; Brigitte Mack; Stefan Endres; Gunther Hartmann; Barbara Wollenberg
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

Review 8.  Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide.

Authors:  Rüdiger Nave
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

9.  Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.

Authors:  Sirlene R Cechin; Peter Buchwald
Journal:  Steroids       Date:  2014-04-18       Impact factor: 2.668

10.  Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide.

Authors:  Gabriele M Böhmer; Anton Drollmann; Christoph H Gleiter; Rüdiger Nave
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.